Interested in joining one of our studies? Please browse our open studies below.
The CANVAS COVID-19 Vaccine Safety Study
The Canadian National Vaccine Safety (CANVAS) Network is a national research platform that monitors vaccine safety after vaccines are approved for use. We are monitoring the safety of the COVID-19 vaccines in Canada and we need your help.
We are recruiting people under 20 years of age who have received their first COVID-19 vaccine in the last 7 days or who are not vaccinated. Using web-based surveys, we will collect information about whether or not there have been any changes to your health after receiving COVID-19 vaccines. We will also collect information on change to your health from people who have not received a COVID-19 vaccine.
The elimination of cervical cancer has been listed by the World Health Organization as a top health priority and Canada is posed to be one of the first countries to achieve this goal. Ongoing evaluation of the HPV vaccine and dosing schedule is critical to optimizing the vaccine’s cancer-eliminating potential.
Women ages 20-27 and men ages 15-20 are invited to participate in this observational study regardless of whether or not they have received the HPV vaccine. Please email email@example.com to learn more.
Special Immunization Clinic (SIC)
This study is collecting information from patients who are attending the Special Immunization Clinic (SIC) due to concerns around receiving vaccines. Researchers are combining the information they get from patient visits, with that of similar patients across Canada, in order to help doctors improve care for other patients who have vaccine concerns in the future.
Creating a Digitally Enhanced AEFI Surveillance System in Canada
This study is examining opportunities for the use of digital technology in adverse event following immunization (AEFI) surveillance in Canada. It has a specific focus on digitally facilitated participant-centred reporting in vaccinated and unvaccinated populations. Digital technology, which has transformed society and healthcare, offers the potential to enhance and improve AEFI surveillance.
PATH Pneumococcal Vaccine Study
Pneumococcal disease is caused by a bacterium called Streptococcus pneumoniae (SP). This bacterium is a major cause of infection of the ears, sinuses, blood, lungs, and brain. Children under 2 years of age and the elderly have the highest rates of disease. Even with antibiotic treatment, many children with severe pneumococcal disease may die or experience severe complications, such as meningitis, pneumonia, septicemia (blood poisoning), hearing loss, or brain damage.
Researchers at the VEC and the University of British Columbia will help to evaluate a new vaccine to protect against 25 strains of SP bacteria. There is a vaccine approved in Canada that protects against the diseases caused by 20 types of SP. However, there are many types of SP responsible for diseases not covered by this vaccine.
You may be able to join the study if you are generally healthy, 18 to 49 years of age, not pregnant, and never received a vaccine against pneumococcal disease.
If you are interested in joining one of our studies or
would like to be added to our contact list, click below.